×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VERU – veru inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VERU
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
01:30 am
veru
Veru (NASDAQ:VERU) was upgraded by analysts at Wall Street Zen from
Low
Report
Veru (NASDAQ:VERU) was upgraded by analysts at Wall Street Zen from
12/18
08:05 am
veru
Veru (NASDAQ:VERU) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $25.00 price target on the stock.
Medium
Report
Veru (NASDAQ:VERU) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $25.00 price target on the stock.
12/18
06:08 am
veru
Veru (NASDAQ:VERU) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Veru (NASDAQ:VERU) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
12/17
02:18 pm
veru
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges [Yahoo! Finance]
Low
Report
Veru Inc (VERU) Q4 2025 Earnings Call Highlights: Strategic Shifts and Financial Challenges [Yahoo! Finance]
12/17
12:03 pm
veru
Veru Inc. (VERU) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Veru Inc. (VERU) Q4 2025 Earnings Call Transcript [Seeking Alpha]
12/17
06:30 am
veru
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
Medium
Report
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
12/10
09:19 am
veru
Veru to Report Fiscal Year 2025 Financial Results on December 17th [Yahoo! Finance]
Low
Report
Veru to Report Fiscal Year 2025 Financial Results on December 17th [Yahoo! Finance]
12/10
08:30 am
veru
Veru to Report Fiscal Year 2025 Financial Results on December 17th
Neutral
Report
Veru to Report Fiscal Year 2025 Financial Results on December 17th
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/17
10:49 am
veru
Form 10-K VERU INC. For: Sep 30
Medium
Report
Form 10-K VERU INC. For: Sep 30
12/17
07:00 am
veru
Form 8-K VERU INC. For: Dec 17
High
Report
Form 8-K VERU INC. For: Dec 17
12/9
12:30 pm
veru
Form 4 VERU INC. For: Dec 05 Filed by: BARNETTE K GARY
Low
Report
Form 4 VERU INC. For: Dec 05 Filed by: BARNETTE K GARY
12/9
12:19 pm
veru
Form 4 VERU INC. For: Dec 05 Filed by: Rankowitz Michael L
Low
Report
Form 4 VERU INC. For: Dec 05 Filed by: Rankowitz Michael L
12/9
12:10 pm
veru
Form 4 VERU INC. For: Dec 05 Filed by: Katzovitz Loren Mark
Low
Report
Form 4 VERU INC. For: Dec 05 Filed by: Katzovitz Loren Mark
12/9
12:00 pm
veru
Form 4 VERU INC. For: Dec 05 Filed by: STEINER MITCHELL SHUSTER
Low
Report
Form 4 VERU INC. For: Dec 05 Filed by: STEINER MITCHELL SHUSTER
12/9
11:50 am
veru
Form 4 VERU INC. For: Dec 05 Filed by: Hyun Grace
Low
Report
Form 4 VERU INC. For: Dec 05 Filed by: Hyun Grace
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/13
Is Paratek Pharmaceuticals Inc (PRTK) Going to Burn These Hedge Funds? [Yahoo! Finance News]
25.0%
12/13 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. 12.1%
6/4 Veru Adds Breakthrough Novel Androgen Deprivation Therapy Formulation to its Advancing Prostate Cancer Drug Pipeline Following Successful Meeting with FDA 8.8%
1/21 Veru Inc (NASDAQ: VERU) had its "reduce" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $4.50. 8.8%
2/19 Form 4 VERU INC. For: Feb 19 Filed by: Socorro Jesus 7.8%
9/28 Veru Inc (NASDAQ: VERU) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. 7.5%
8/28 Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York 6.6%
3/4 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 5.1%
5/3 Form 4 VERU INC. For: May 01 Filed by: STEINER MITCHELL SHUSTER 4.1%
11/2 Veru Inc (NASDAQ: VERU) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 4.1%
12/13 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. 12.1%
6/4 Veru Adds Breakthrough Novel Androgen Deprivation Therapy Formulation to its Advancing Prostate Cancer Drug Pipeline Following Successful Meeting with FDA 8.8%
1/21 Veru Inc (NASDAQ: VERU) had its "reduce" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $4.50. 8.8%
2/19 Form 4 VERU INC. For: Feb 19 Filed by: Socorro Jesus 7.8%
9/28 Veru Inc (NASDAQ: VERU) had its "hold" rating re-affirmed by analysts at Zacks Investment Research. 7.5%
8/28 Veru to Participate at Three Upcoming Healthcare Investor Conferences in New York 6.6%
3/4 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 5.1%
5/3 Form 4 VERU INC. For: May 01 Filed by: STEINER MITCHELL SHUSTER 4.1%
11/2 Veru Inc (NASDAQ: VERU) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 4.1%
TOP News Decliners
8/27
Veru to Ring NASDAQ Closing Bell on September 4th to Kick Off National Prostate Cancer Awareness Month
-9.5%
8/8 Veru Reports Higher Net Revenues and Gross Profit for its Fiscal 2019 Third Quarter -9.4%
12/12 Form 8-K VERU INC. For: Dec 12 -7.7%
8/9 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. -7.5%
5/15 Q2/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.050 ActVsEst (0.010) - Miss -7.1%
6/6 Veru Inc (NASDAQ: VERU) was given a new $5.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. -6.3%
8/1 Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th -6.3%
1/28 Form DEF 14A VERU INC. For: Mar 24 -5.4%
1/25 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.4%
1/13 Veru's experimental drug reduces hot flashes in men in mid-stage study [Reuters (UK)] -3.9%
8/8 Veru Reports Higher Net Revenues and Gross Profit for its Fiscal 2019 Third Quarter -9.4%
12/12 Form 8-K VERU INC. For: Dec 12 -7.7%
8/9 Veru Inc (NASDAQ: VERU) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock. -7.5%
5/15 Q2/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.050 ActVsEst (0.010) - Miss -7.1%
6/6 Veru Inc (NASDAQ: VERU) was given a new $5.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. -6.3%
8/1 Veru to Report Fiscal 2019 Third-Quarter Financial Results; Host Conference Call on August 8th -6.3%
1/28 Form DEF 14A VERU INC. For: Mar 24 -5.4%
1/25 Veru Inc (NASDAQ: VERU) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.4%
1/13 Veru's experimental drug reduces hot flashes in men in mid-stage study [Reuters (UK)] -3.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: